Relationship between serum IgA/C3 ratio and progression of IgA nephropathy

Internal Medicine

Volumn 43, Issue 11, 2004, Pages 1023-1028

  Komatsu, Hiroyuki ^a   Fujimoto, Shouichi ^a   Hara, Seiichiro ^a   Sato, Yuji ^a   Yamada, Kazuhiro ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Complement; Hematuria; IgA nephropathy; Serum IgA; Serum IgA C3 ratio

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN BLOOD LEVEL; JAPAN; KAPLAN MEIER METHOD; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PROGNOSIS; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

ADULT; COMPLEMENT C3; DISEASE PROGRESSION; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; MALE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 10244229792     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.1023     Document Type: Article

References (25)

1. Berger J, Hinglais N. Intercapillary deposits of IgA-IgG. J Urol Nephrol (Paris) 74: 694-695, 1968.
2. Whitworth JA, Leibowitz S, Kennedy MC, Cameron JS, Chantler C. IgA and glomerular disease. Clin Nephrol 5: 33-36, 1976.
3. Waldo FB. Role of IgA in IgA nephropathy. J Pediatr 116 S78-85, 1990.
4. Wyatt RJ, Kanayama Y, Julian BA, et al. Complement activation in IgA nephropathy. Kidney Int 31: 1019-1023, 1987.
5. Whicher JT, Ritchie RF, Johnson AM, et al. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 40: 934-938, 1994.
6. Itoh Y, Ichihara K, Kanno T, et al. Serum protein standardization project in Japan: Evaluation of an IFCC reference material (RPPHS/CRM470) and establishment of reference intervals. J Clin Lab Anal 11: 39-44, 1997.
7. Tomino Y, Suzuki S, Imai H, et al. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 14: 220-223, 2000.
8. Ishiguro C, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Serum IgA/C3 ratio may predict diagnosis and prognostic grading in patients with IgA nephropathy. Nephron 91: 755-758, 2002.
9. Tomino Y, Sakai H, Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 7: 93-97, 2003.
10. Egido J, Blasco R, Sancho J, Lozano L, Sanchez-Crespo M, Hernando L. Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol 47: 309-316, 1982.
11. Bene MC, Hurault De Ligny B, Kessler M, Faure GC. Confirmation of tonsillar anomalies in IgA nephropathy: A multicenter study. Nephron 58: 425-428, 1991.
12. Itoh A, Iwase H, Takatani T, et al. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients. Nephrol Dial Transplant 18: 1108-1114, 2003.
13. Horie A, Hiki Y, Odani H, et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am J Kidney Dis 42: 486-496, 2003.
14. van den Wall Bake AW, Daha MR, Evers-Schouten J, van Es LA. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: Evidence for the bone marrow as the source of mesangial IgA. Am J Kidney Dis 12: 410-414, 1988.
15. van den Wall Bake AW, Daha MR, Radl J, et al. The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy. Clin Exp Immunol 72: 321-325, 1988.
16. Harper SJ, Allen AC, Layward L, Hattersley J, Veitch PS, Feehally J. Increased immunoglobulin A and immunoglobulin A1 cells in bone marrow trephine biopsy specimens in immunoglobulin A nephropathy. Am J Kidney Dis 24: 888-892, 1994.
17. Imasawa T, Nakazawa R, Utsunomiya Y, et al. Bone marrow transplantation attenuates murine IgA nephropathy: Role of a stem cell disorder. Kidney Int 56: 1809-1817, 1999.
18. Imasawa T, Utsunomiya Y. Stem cells in renal biopsy: Bone marrow transplantation for the treatment of IgA nephropathy. Exp Nephrol 10: 51-58, 2002.
19. Rantala I, Mustonen J, Hurme M, Syrjanen J, Helin H. Pathogenetic aspects of IgA nephropathy. Nephron 88: 193-198, 2001.
20. Emancipator SN. IgA nephropathy and Henoch-Schonlein syndrome. in: Heptinstall's Pathology of the Kidney. 5th ed. Jennette JC, Olson JL, Schwartz MM, Silva FG, Eds. Lippincott-Raven Publishers, Philadelphia, 1998: 480-513.
21. Abou-Ragheb HH, Williams AJ, Brown CB, Milford-Ward A. Plasma levels of the anaphylatoxins C3a and C4a in patients with IgA nephropathy/Henoch-Schonlein nephritis. Nephron 62: 22-26, 1992.
22. Zwirner J, Burg M, Schulze M, et al. Activated complement C3: A potentially novel predictor of progressive IgA nephropathy. Kidney Int 51: 1257-1264, 1997.
23. Janssen U, Bahlmann F, Kohl J, Zwirner J, Haubitz M, Floege J. Activation of the acute phase response and complement C3 in patients with IgA nephropathy. Am J Kidney Dis 35: 21-28, 2000.
24. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis 31: 962-970, 1998.
25. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 347 738-748, 2002.